Association of intra‐tumoral tumour‐infiltrating lymphocytes and neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in non‐small cell lung cancer

Abstract

This study is first report demonstrating the prognostic value of intra-tumoral low CD5⁺ with NSCLC. Increased CD3⁺ and low CD5⁺ was observed in patients with poor prognosis; the two molecules were correlated with NLR, suggesting that inflammation might be used as improve therapeutic efficacy to immunotherapy for advanced NSCLC.